Anthem Biosciences Limited (ANTHEM): research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Anthem Biosciences Limited, explained in plain English.

• ▪Anthem Biosciences Limited is tracked in the Pharma & Healthcare sector of the NSE universe covered here.
• ▪ANTHEM closed at ₹830.15 on 29 October 2026.
• ▪Over the past year the shares are up 14.2%, trading between ₹579.15 and ₹977.55.
• ▪Reported fundamentals show a net margin of 28.69%, debt to equity of 1.77.
• ▪Our transparent MaxGrade checklist scores it D (41/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 28.79% with a maximum drawdown of -17.42% and a beta of 0.5 against NIFTY 50.
• ▪Recent coverage: Anthem Biosciences block deal: Portsmouth Technologies sells 30 lakh shares worth Rs 250 crore

Other Pharma & Healthcare companies: Abbott India, Acutaas Chemicals, Ajanta Pharmaceuticals, Alkem Laboratories, Apollo Hospitals Enterprise, Aster DM Quality Care, Aurobindo Pharma, Biocon

Last traded values from 29 Oct 2026. Market opens at 9:15 IST.